DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0020255 | Hydrocephalus | RXYLT1 | 10329 | ribitol xylosyltransferase 1 | Q9Y2B1 |
C0007131 | Non-Small Cell Lung Carcinoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0027651 | Neoplasms | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0006826 | Malignant Neoplasms | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0007847 | Malignant tumor of cervix | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0700095 | Central neuroblastoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0021400 | Influenza | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C1306459 | Primary malignant neoplasm | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C4048328 | cervical cancer | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0302592 | Cervix carcinoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0027819 | Neuroblastoma | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0343641 | Human papilloma virus infection | B3GNT3 | 10331 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Q9Y2A9 |
C0011854 | Diabetes Mellitus, Insulin-Dependent | CEPT1 | 10390 | choline/ethanolamine phosphotransferase 1 | Q9Y6K0 |
C0028754 | Obesity | CEPT1 | 10390 | choline/ethanolamine phosphotransferase 1 | Q9Y6K0 |
C0024141 | Lupus Erythematosus, Systemic | CEPT1 | 10390 | choline/ethanolamine phosphotransferase 1 | Q9Y6K0 |
C1306459 | Primary malignant neoplasm | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0006118 | Brain Neoplasms | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0038454 | Cerebrovascular accident | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0006826 | Malignant Neoplasms | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0338831 | Manic | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0007097 | Carcinoma | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0205696 | Anaplastic carcinoma | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0018802 | Congestive heart failure | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C1306459 | Primary malignant neoplasm | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
C0027651 | Neoplasms | CDS1 | 1040 | CDP-diacylglycerol synthase 1 | Q92903 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024